Protein degradation as a target for anticancer therapy: molecular mechanisms of efficacy and acquired resistance to proteasome and aminopeptidase inhibitors

Authors :: Peters, G. J.
Ossenkoppele, G. J.
Cloos, J.
Jansen, G.
Medical oncology laboratory
CCA - Target Discovery & Preclinial Therapy Development
Hematology
Hematology laboratory
Rheumatology
Source :: Amino Acids, 48(2), 616-616. Springer Wien, Peters, G J, Ossenkoppele, G J, Cloos, J & Jansen, G 2016, ' Protein degradation as a target for anticancer therapy: molecular mechanisms of efficacy and acquired resistance to proteasome and aminopeptidase inhibitors ', Amino Acids, vol. 48, no. 2, pp. 616-616 .
Publication Year :: 2016

Language :: English
ISSN :: 09394451
Database :: OpenAIRE
Journal :: Amino Acids, 48(2), 616-616. Springer Wien, Peters, G J, Ossenkoppele, G J, Cloos, J & Jansen, G 2016, ' Protein degradation as a target for anticancer therapy: molecular mechanisms of efficacy and acquired resistance to proteasome and aminopeptidase inhibitors ', Amino Acids, vol. 48, no. 2, pp. 616-616 .
Accession number :: edsair.dedup.wf.001..f0d7f4d69be575c54e61def8303a3d12

Tools